Caroline Tillett - 01 Dec 2025 Form 4 Insider Report for Kenvue Inc. (KVUE)

Role
Chief Scientific Officer
Signature
/s/ Alla Berenshteyn, as attorney-in-fact
Issuer symbol
KVUE
Transactions as of
01 Dec 2025
Transactions value $
-$13,569
Form type
4
Filing time
03 Dec 2025, 17:06:23 UTC
Previous filing
12 Mar 2025
Next filing
17 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tillett Caroline Chief Scientific Officer 1 KENVUE WAY, SUMMIT /s/ Alla Berenshteyn, as attorney-in-fact 03 Dec 2025 0001966949

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KVUE Common Stock Options Exercise $0 +1.54K +3.49% $0.00 45.7K 01 Dec 2025 Direct F1
transaction KVUE Common Stock Tax liability -$13.6K -788 -1.73% $17.22 44.9K 01 Dec 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KVUE Restricted Stock Units Options Exercise $0 -1.54K -50% $0.00 1.54K 01 Dec 2025 Common Stock 1.54K Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These units correspond 1 for 1 with the Company's common stock.
F2 Shares withheld for payment of taxes upon vesting of Restricted Share Units (RSUs).
F3 This award vests in three equal installments on 12/01/2024, 12/01/2025, and 12/01/2026, subject to the reporting person's continued service through the vesting date.
F4 Includes RSUs acquired in dividend reinvestment transactions.